D'Aloja Paola, Santarcangelo Anna Claudia, Arold Stefan, Baur Andreas, Federico Maurizio
University of Erlangen, Department of Dermatology, Erlangen, Germany2.
Laboratory of Virology, Istituto Superiore di Sanità, Viale Regina Elena, 299, 00161 Rome, Italy1.
J Gen Virol. 2001 Nov;82(Pt 11):2735-2745. doi: 10.1099/0022-1317-82-11-2735.
The primary human immunodeficiency virus type 1 (HIV-1) Nef mutant F12-HIVNef is characterized by three rare amino acid substitutions, G(140)E, V(153)L and E(177)G. It was reported previously that the expression of F12-HIVNef in the context of the highly productive NL4-3 HIV-1 strain blocks virus replication at the level of virus assembly and/or release by a mechanism depending on the presence of the CD4 intracytoplasmic tail. Here, it is reported that NL4-3 HIV-1 strains expressing F12-HIVnef alleles that were back-mutated in each amino acid substitution readily replicated in CD4(+) cells. Attempting to correlate possible functional alterations with antiviral effects, both F12-HIVNef and its back mutants were tested in terms of well-characterized markers of Nef expression. Both F12-HIVNef and its G(177)E back mutant did not down-regulate CD4 as the consequence of a greatly reduced rate of CD4 internalization. On the other hand, F12-HIVNef as well as the E(140)G and L(153)V back mutants failed to activate the p62 Nef-associated kinase (p62NAK). Thus, only F12-HIVNef was defective in both accelerated rates of CD4 internalization and p62NAK activation, whereas at least one Nef function was restored in all of the back mutants. Infection of cells expressing Nef-resistant CD4 molecules with HIV-1 strains encoding F12-HIVNef back mutants showed that both the lack of accelerated CD4 endocytosis and an, as yet, still unidentified function are required for the F12-HIVNef inhibitory phenotype. These results provide a detailed functional analysis of the F12-HIVnef allele and support the idea that both CD4 accelerated internalization and p62NAK activation are part of the essential steps in the virus replication cycle.
主要的1型人类免疫缺陷病毒(HIV-1)Nef突变体F12-HIVNef具有三个罕见的氨基酸替换,即G(140)E、V(153)L和E(177)G。先前有报道称,在高生产性的NL4-3 HIV-1毒株背景下表达F12-HIVNef会通过一种依赖于CD4胞质内尾巴存在的机制在病毒组装和/或释放水平上阻断病毒复制。在此,有报道称表达在每个氨基酸替换中发生回突变的F12-HIVnef等位基因的NL4-3 HIV-1毒株能够在CD4(+)细胞中轻易复制。为了将可能的功能改变与抗病毒效应联系起来,对F12-HIVNef及其回突变体进行了Nef表达的特征明确的标志物检测。F12-HIVNef及其G(177)E回突变体均未下调CD4,这是由于CD4内化速率大幅降低所致。另一方面,F12-HIVNef以及E(140)G和L(153)V回突变体未能激活p62 Nef相关激酶(p62NAK)。因此,只有F12-HIVNef在加速的CD4内化速率和p62NAK激活方面均存在缺陷,而在所有回突变体中至少恢复了一种Nef功能。用编码F12-HIVNef回突变体的HIV-1毒株感染表达对Nef有抗性的CD4分子的细胞表明,F12-HIVNef抑制表型需要同时缺乏加速的CD4内吞作用和一种尚未明确的功能。这些结果对F12-HIVnef等位基因进行了详细的功能分析,并支持了CD4加速内化和p62NAK激活都是病毒复制周期中关键步骤的观点。